Abstract:ImportanceAnimal studies have shown that the adolescent brain is sensitive to disruptions in endocannabinoid signaling, resulting in altered neurodevelopment and lasting behavioral effects. However, few studies have investigated ties between cannabis use and adolescent brain development in humans.ObjectiveTo examine the degree to which magnetic resonance (MR) imaging–assessed cerebral cortical thickness development is associated with cannabis use in a longitudinal sample of adolescents.Design, Setting, and ParticipantsData were obtained from the community-based IMAGEN cohort study, conducted across 8 European sites. Baseline data used in the present study were acquired from March 1, 2008, to December 31, 2011, and follow-up data were acquired from January 1, 2013, to December 31, 2016. A total of 799 IMAGEN participants were identified who reported being cannabis naive at study baseline and had behavioral and neuroimaging data available at baseline and 5-year follow-up. Statistical analysis was performed from October 1, 2019, to August 31, 2020.Main Outcomes and MeasuresCannabis use was assessed at baseline and 5-year follow-up with the European School Survey Project on Alcohol and Other Drugs. Anatomical MR images were acquired with a 3-dimensional T1-weighted magnetization prepared gradient echo sequence. Quality-controlled native MR images were processed through the CIVET pipeline, version 2.1.0.ResultsThe study evaluated 1598 MR images from 799 participants (450 female participants [56.3%]; mean [SD] age, 14.4 [0.4] years at baseline and 19.0 [0.7] years at follow-up). At 5-year follow-up, cannabis use (from 0 to >40 uses) was negatively associated with thickness in left prefrontal (peak:t785 = –4.87, cluster size = 1558 vertices;P = 1.10 × 10−6, random field theory cluster corrected) and right prefrontal (peak:t785 = –4.27, cluster size = 1551 vertices;P = 2.81 × 10−5, random field theory cluster corrected) cortices. There were no significant associations between lifetime cannabis use at 5-year follow-up and baseline cortical thickness, suggesting that the observed neuroanatomical differences did not precede initiation of cannabis use. Longitudinal analysis revealed that age-related cortical thinning was qualified by cannabis use in a dose-dependent fashion such that greater use, from baseline to follow-up, was associated with increased thinning in left prefrontal (peak:t815.27 = –4.24, cluster size = 3643 vertices;P = 2.28 × 10−8, random field theory cluster corrected) and right prefrontal (peak:t813.30 = –4.71, cluster size = 2675 vertices;P = 3.72 × 10−8, random field theory cluster corrected) cortices. The spatial pattern of cannabis-related thinning was associated with age-related thinning in this sample (r = 0.540;P < .001), and a positron emission tomography–assessed cannabinoid 1 receptor–binding map derived from a separate sample of participants (r = −0.189;P < .001). Analysis revealed that thinning in right prefrontal cortices, from baseline to follow-up, was associated with attentional impulsiveness at follow-up.Conclusions and RelevanceResults suggest that cannabis use during adolescence is associated with altered neurodevelopment, particularly in cortices rich in cannabinoid 1 receptors and undergoing the greatest age-related thickness change in middle to late adolescence.

Cannabis Use and Subclinical Positive Psychotic Experiences in Early Adolescence: Findings from a Dutch Survey.

Cannabis Use at A Young Age is Associated with Psychotic Experiences

Cannabis Use As An Indicator Of Risk For Mental Health Problems In Adolescents: A Population-Based Study At Secondary Schools

Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.

Cannabis Use and Psychosis: A Longitudinal Population-based Study

INITIAL AGE AND AMOUNT OF CANNABIS EXPOSURE ARE STRONGLY ASSOCIATED WITH PSYCHOSIS VULNERABILITY IN A SAMPLE OF 18,000 DUTCH ADOLESCENTS

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

Age-dependent association of cannabis use with risk of psychotic disorder

Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults.

Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study

Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis

Effect of Cannabis Use on the Course of Schizophrenia in Male Patients: A Prospective Cohort Study

Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence from the Population-Based World Health Organization World Mental Health Survey Initiative.

Cannabis Use and Age at Onset of Schizophrenia

Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.

Observed Trajectories of Cannabis Use and Concurrent Longitudinal Outcomes in Youth and Young Adults Receiving Coordinated Specialty Care for Early Psychosis

Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years

Association between cannabis and psychiatric hospitalization.

Association of Cannabis Use During Adolescence With Neurodevelopment